Abstract:Objective: To explore the therapeutic potential of endothelial progenitor cells (EPCs) transfected with vascular endothelial growth factor A (VEGFA) and heme oxygenase-1 (HO-1) on rat hindlimb ischemia model.Methods: Eukaryotic expression vectors encoding VEGFA or HO-1 were constructed and introduced into EPCs isolated from rat bone marrow. In total, 150 Sprague Dawley rat hindlimb ischemia models were established and randomized into five groups which were injected via tail vein with phosphate-buffered saline (PBS), nontransfected EPCs, VEGFA-modified EPCs, HO-1-modified EPCs, and both VEGFA- and HO-1-modified EPCs, respectively. The microvessel density, the expressions of VEGFA and HO-1 in the ischemic limbs, the recovery of blood flow as evaluated by laser-Doppler perfusion imaging, and the rate of limb salvage were compared among different groups.Results: Transplantation of both VEGFA- and HO-1-modified EPCs in recipient rats significantly increased the microvessel density (expressed as capillaries/m(2) at day 21 after operation, group vascular endothelial growth factor (VEGF) + HO-1, 357 +/- 14.1; group VEGF, 253.7 +/- 9.9; group HO-1, 255.5 +/- 12.5; group EPC, 210.7 +/- 10.3; group PBS, 144.3 +/- 9.3; P < .001), the expressions of VEGFA and HO-1 in ischemic tissue, the recovery of blood flow (at day 21, VEGF+HO-1 group, 85.4 +/- 17.8%; VEGF group, 51.2 +/- 13.2%; HO-1 group, 50.4 +/- 12.9%; EPC group, 39.9 +/- 8.5%; PBS group, 28.3 +/- 7.8%; P < .001), and the rate of limb salvage (VEGF+HO-1 group, 94.4%; VEGF group or HO-1 group, 63.6%; EPC group, 50.0%; PBS group, 11.1%), compared with transplantation of either VEGFA- or HO-1-modified EPCs alone, or of nontransfected EPCs, or PBS injection. The order of therapeutic effectiveness on ischemic limbs was VEGFA- + HO-1-modifed EPC > either VEGFA- or HO-1-modified EPC alone > nontransfected EPC > PBS.Conclusions: VEGFA-modified EPC and HO-1-modified EPC synergized with each other in promoting angiogenesis in ischemic limbs of rat hindlimb ischemia model. In addition to VEGF, the introduction of HO-1 in EPC-based transplantation may serve as a novel and useful therapeutic strategy for ischemic disease of lower extremity.

Endothelium-targeted delivery of PPARδ by adeno-associated virus serotype 1 ameliorates vascular injury induced by hindlimb ischemia in obese mice.

Endothelium-targeted delivery of PPAR8 by adeno-associated virus serotype 1 ameliorates vascular injury induced by hindlimb ischemia in obese mice

Endothelial PPARδ facilitates the post-ischemic vascular repair through interaction with HIF1α

Adipose stromal cell and sarpogrelate orchestrate the recovery of inflammation-induced angiogenesis in aged hindlimb ischemic mice.

PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway

PPARδ activation protects endothelial function in diabetic mice

Ultrasound-induced Microbubble Destruction Promotes Targeted Delivery of Adipose-Derived Stem Cells to Improve Hind-Limb Ischemia of Diabetic Mice.

A Novel Angiogenesis Role of GLP-1(32-36) to Rescue Diabetic Ischemic Lower Limbs Via GLP-1R-Dependent Glycolysis

Endothelial Deletion of Mtorc1 Protects Against Hindlimb Ischemia in Diabetic Mice Via Activation of Autophagy, Attenuation of Oxidative Stress and Alleviation of Inflammation.

Abstract 606: Pharmacological Inhibition of PAI-1 Rescues Blood Flow Perfusion Through Promoting Capillary Arterialization in Diabetic Microangiopathy in Ischemic Limb

Estrogen-Related Receptor Gamma Gene Therapy Promotes Therapeutic Angiogenesis and Muscle Recovery in Preclinical Model of PAD

Apelin prevents diabetes-induced poor collateral vessel formation and blood flow reperfusion in ischemic limb

Anti-vascular Endothelial Growth Factor Treatment Induces Blood Flow Recovery Through Vascular Remodeling in High-Fat Diet Induced Diabetic Mice.

Transplantation of Normal Adipose Tissue Improves Blood Flow and Reduces Inflammation in High Fat Fed Mice with Hindlimb Ischemia (vol 9, 197, 2018)

Prolyl hydroxylase domain-2 silencing induced by hydrodynamic limb vein injection enhances vascular regeneration in critical limb ischemia mice through activation of multiple genes.

The Therapeutic Effect of Vascular Endothelial Growth Factor Gene- or Heme Oxygenase-1 Gene-Modified Endothelial Progenitor Cells on Neovascularization of Rat Hindlimb Ischemia Model.

PPARδ Is Required for Exercise to Attenuate Endoplasmic Reticulum Stress and Endothelial Dysfunction in Diabetic Mice

Co-Delivery of Bioengineered Exosomes and Oxygen for Treating Critical Limb Ischemia in Diabetic Mice

Vascular Regeneration in Ischemic Hindlimb by Adeno‐Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth Factor

Modulation of miR-29a and ADAM12 Reduces Post-Ischemic Skeletal Muscle Injury and Improves Perfusion Recovery and Skeletal Muscle Function in a Mouse Model of Type 2 Diabetes and Peripheral Artery Disease

SYNERGISTIC ADIPOSE-DERIVED STROMAL CELLS AND SARPOGRELATE RECOVER THE IMPAIRED ANGIOGENESIS AND INFLAMMATION MODULATORY FUNCTION IN AGED HINDLIMB ISCHAEMIA MICE